Breaking Barriers in bioanalytical automation
TRADITIONAL PHARMA FACILITIES
Redefining Pharmaceutical Research and Training with Digital Twins and AI
Why Pharma Products still go to Waste and How Better Logistics can Help
Microbiological QC Bottlenecks in Biopharma
EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
From Hallucinations to Evidence: LLMs clinicians can finally trust
Research Fellow, Institute of Health Informatics, University College London
Jinge Wu is a Research Fellow at the UCL Institute of Health Informatics specialising in multimodal large language models for clinical decision support and medical AI She has led research projects funded by UKRI MRC and Health Data Research UK working with largescale NHS electronic health record data to develop capable reliable and explainable AI for realworld clinical applications Her research ha...
Articles
Chemistry & AI
Disruptive technologies have consistently played a pivotal role in reshaping various aspects of our lives leading to significant improvements in efficiency and effectiveness Among these transformative innovations artificial intelligence AI and machine learning ML have garnered considerable attention
Research Insights
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine
Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to in
Case Studies
Novel Vaccines - Heat Stable Anthrax Vaccine
Challenge Existing approved Anthrax vaccines are based on cellfree filtrates of disintegrated cells of Bacillus anthracis adsorbed onto an aluminiumhydrogel adjuvant A number of side effects are attributed to these vaccines including poor safety profile and a low immunogenicity necessitating repea
Techno Trends
India's Biotech Sector Experiences Surge in Investment Amid Global Challenges
Indias biotechnology sector is attracting unprecedented investment flows as it adapts to global market challenges
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
The Role of Artificial Intelligence in Advancing Pharmacovigilance Systems
Rahul Jaiswal is an Assistant Professor at Hygia College of Pharmacy, Lucknow, and a Research Scholar at Integral University, Lucknow. He has been associated with CSIR-CDRI, Lucknow, and has published several articles. His expertise includes molecular techniques, histopathology, and innovative pharmaceutical research, with contributions to national and international conferences.
When Orphan Drugs Make All the Difference
Sue Lee has worked for World Courier for 25 years. During this time she has experienced a variety of customer service and operational functions, including the setting up of numerous, multi-national, clinical sites for the transportation of biological samples. She orchestrated the shipping of thousands of shipments with very specific temperature requirements to a host of challenging locations, and each presenting their own obstacles and dilemmas.
Tiny Vesicles, Big Impact
Dr. Disha Marwaha received her PhD in biological sciences from CSIR-Central Drug Research Institute (CSIR-CDRI), India in 2024. She is currently an Assistant Professor at the GLA University, Mathura. She has more than 20 publications in international peer-reviewed Journals. She is an expert in formulation and development, nanomedicine and pharmacokinetics focusing on innovative therapeutic and targeted drug delivery systems.
Dr. Neha Singh received her Ph.D. in Biological Sciences from the CSIR-Central Drug Research Institute (CSIR-CDRI), India, in 2025. She is currently an Assistant Professor at the Lloyd School of Pharmacy, Greater Noida. Dr. Singh has contributed extensively to the field of pharmaceutical sciences, with many publications, patents, and book chapters in internationally recognised peer-reviewed journals. Her primary research interests include formulation development, nanomedicine and pharmacokinetics, with a focus on innovative therapeutic strategies and targeted drug delivery systems. Dr. Singh’s work reflects her commitment to advancing precision medicine and developing next-generation solutions for healthcare.
Rethinking How Medicines Work
Dr. Asawari Pagare is a bioinformatician at UW Medicine where she studies the genomics of myositis, an autoimmune disease that is not yet well understood. She earned her PhD in Chemistry from the University of North Carolina at Chapel Hill, USA, where she explored how timing and fluctuations influence how living systems interpret signals relevant to medicine.
Envisioning the Biomanufacturing Facility of the Future
Merrilee is the Head of the BioContinuum™ Platform, driving the strategy and execution of Process Intensification Technologies, Software & Automation, and Analytics to meet the needs of biologics manufacturers. Throughout her 15 years at MilliporeSigma, she managed multiple product lines including clarification, aseptic, virus filtration, and Single Use & Systems.
press releasesRead more...
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
ACROBiosystems announced a major upgrade to its global license solution for HEK functional cell lines Centered on customer value and empowering global biopharmaceutical innovation
Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies
Delos Capital Delos and AP Biosciences Inc APBio today announced a strategic collaboration to create and incubate new biotechnology companies The parties initial focus is the discovery
Hokkaido University and BostonGene are using their AI-powered genome profiling platform to advance precision cancer treatment.
BostonGene a developer of AI for cancer and immunology today announced a research partnership with Hokkaido University This multiyear initiative aims to support the advancement of precision medicine
Sino Biological Unveils EliteScience VIP Partnership Program for European Researchers
Sino Biological Europe GmbH the regional subsidiary of global life science reagent and service provider Sino Biological has recently launched its EliteScience VIP Partnership program an exclusive premium service
SK pharmteco Collaborates with Axle Informatics and the National Institutes of Health to Advance Rare Disease Gene Therapy Programs
SK pharmteco today announced a strategic partnership with Axle Informatics and the National Institutes of Health NIH to advance the development of gene therapies for rare diseases This partnership focused on viral vector programs underscores SK pharmtecos commitment
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
Novartis a leading global innovative medicines company today broke ground on its new sq ft radioligand therapy RLT manufacturing site in Denton Texas the latest milestone in its broader billion investment in US manufacturing and research The start of construction
EventsRead more...
10 - 14
May 2026Respiratory Drug Delivery 2026
The Westin Kierland Phoenix, Arizona, USA
14 - 14
May 2026PDA Microbiology in CCS Workshop 2026
Singapore
20 - 21
May 2026Pharmacovigilance Europe 2026
London, UK
20 - 21
May 2026Pharma Partnering EU Summit 2026
Pharma Partnering Summit
Basel Marriott Hotel, Switzerland
20 - 22
May 2026PHARMA EURASIA 2026
Pharma & Med Tech Park, Tashkent, Uzbekistan
21 - 22
May 2026Liver Diseases & Hepatology 2026
Paris, France
27 - 28
May 2026Digi-Tech Pharma & AI Conference
London, United Kingdom
27 - 28
May 2026Global Clinical Trials Connect 2026
London, United Kingdom
LATEST NEWSRead more...
Erasca Enters into Collaboration with Merck to Evaluate ERAS-0015 with KEYTRUDA in RAS-Mutant Solid Tumours
Erasca has entered into a clinical trial collaboration and supply agreement with Merck to evaluate ERAS in combination with KEYTRUDA for patients with RASmutant solid tumours
Hengrui Pharma Enters into Collaboration with Bristol Myers Squibb to Advance Innovative Therapies
Hengrui Pharma and Bristol Myers Squibb have entered into global strategic collaboration and licensing agreements to develop a portfolio of earlystage programmes across oncology haematology and immunology
Zai Lab Receives FDA Fast Track Status for DLL3-Targeting ADC in epNEC Treatment
Zai Lab has received Fast Track Designation from the US Food and Drug Administration for zocilurtatug pelitecan zoci formerly ZL an investigational DLLtargeting antibodydrug conjugate ADC
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
Altasciences a fully integrated drug development solution company and Certara a global leader in modelinformed drug development MIDD today announced a strategic partnership to accelerate earlyphase development programs
Halozyme Announces Global Collaboration and License Agreement with GSK to Develop Subcutaneous Formulations of Multiple Promising Oncology Targets
Halozyme Therapeutics Inc announced the Company entered into a global collaboration and license agreement with GSK Under the collaboration GSK has licensed Halozymes ENHANZE drug delivery technology for the development and potential commercialization of subcutaneous administration
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
Roche announced today that it has entered into a definitive merger agreement to acquire PathAI a USbased company in digital pathology and AIpowered technology for pathology laboratories and the biopharma industry
